Immatics (IMTX) Other financing activities (2019 - 2024)
Immatics (IMTX) reported Other financing activities of -$826959.3 for Q3 2024, down 101.52% on a YoY basis from $54.3 million in Q4 2023, and down 101.52% sequentially from $54.3 million in Q3 2023.
Immatics (IMTX) Other financing activities (2019 - 2024) Analysis & Trends
Immatics (IMTX) has 5 years of Other financing activities data on file, last reported at -$826959.3 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -826,959.29 |
| Sep 30, 2024 | -826,959.29 |
| Sep 30, 2023 | 54.32 Mn |
| Sep 30, 2023 | 54.32 Mn |
| Mar 31, 2021 | -581.41 Mn |
| Mar 31, 2021 | -581.41 Mn |
| Sep 30, 2020 | 244.02 Bn |
| Sep 30, 2020 | 244.02 Bn |
| Jun 30, 2020 | -613.51 Mn |
| Jun 30, 2020 | -613.51 Mn |
| Mar 31, 2020 | -674.51 Mn |
| Mar 31, 2020 | -674.51 Mn |
| Sep 30, 2019 | -558.59 Mn |
| Sep 30, 2019 | -558.59 Mn |